On Oct. 19, 2020, ICON announced that it had been re-selected by the Biomedical Advanced Research and Development Authority (BARDA) to continue being part of its exclusive Medical Countermeasures Clinical Studies Network (CSN).

Headquartered in Dublin, Ireland, ICON operated from 94 locations in 40 countries and had approximately 15,250 employees as of Sept. 30, 2020.